Although these events could be explained by ameliorating hyperglycaemia and improving insulin levels, EA also reduced levels of ROS and MDA and the nuclear activation of NF-κB and stimulated the nuclear activity and levels of GSH and SOD in the livers of control rats. The gene discussed is SOD1; the disease is Hyperglycemia.